pharma · Pain · Hyponatremia · CPIX
Cumberland Pharmaceuticals
CUMBERLAND PHARMACEUTICALS INC
Cumberland Pharmaceuticals is a pharma organization headquartered in Nashville, USA. It trades on NYSE under ticker CPIX. Primary therapeutic focus areas include Pain, Hyponatremia, Fever, Colonoscopy Preparation, Kidney
1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1600 W End Ave, #1300, Nashville, Tennessee 37203, US
- Founded
- 1999
- Employees
- 128
- Programs
- 53
- Drugs
- 26
- Patents
- 34
conivaptan hydrochloride
Phase 1 · small molecule · Liver Disease
conivaptan hydrochloride for Liver Disease is a Phase 1 program (small_molecule) at CUMBERLAND PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Internal code 087-CL-099
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CUMBERLAND PHARMACEUTICALS INC
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Liver Disease
- Status
- completed
- Trials
- 2